Last C$0.07 CAD
Change Today +0.005 / 7.69%
Volume 145.8K
ADK On Other Exchanges
Symbol
Exchange
Venture
OTC US
Berlin
As of 3:53 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

diagnos inc (ADK) Snapshot

Open
C$0.07
Previous Close
C$0.07
Day High
C$0.07
Day Low
C$0.06
52 Week High
12/3/13 - C$0.14
52 Week Low
09/26/14 - C$0.05
Market Cap
7.4M
Average Volume 10 Days
85.0K
EPS TTM
C$-0.03
Shares Outstanding
106.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DIAGNOS INC (ADK)

Related News

No related news articles were found.

diagnos inc (ADK) Related Businessweek News

No Related Businessweek News Found

diagnos inc (ADK) Details

DIAGNOS Inc. provides data mining and interpretation consulting services, and designs advanced data analytics software products. The company offers data mining consulting services through Computer Aided Resource Detection System, a software tool that assists exploration companies in identifying mining deposits, as well as target generation and project management services in the natural resources sector. It also provides image analysis services through Computer Assisted Retinal Analysis, a hosted Web-based application software that assists health specialists in the detection of diabetic retinopathy for the healthcare sector. The company was founded in 1998 and is based in Brossard, Canada.

Founded in 1998

diagnos inc (ADK) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: C$200.0K
Chief Financial Officer, Vice-President - Fin...
Total Annual Compensation: C$116.1K
Vice-President of Business Development
Total Annual Compensation: C$105.0K
Vice President of Development & Business Inte...
Total Annual Compensation: C$130.0K
Compensation as of Fiscal Year 2014.

diagnos inc (ADK) Key Developments

Diagnos Inc. Signs Contract with Global Pharmaceutical Company for Screening Project in Eastern Europe

Diagnos Inc. announced the signing of a contract with a large global pharmaceutical company for a screening project in Eastern Europe. After running successful screening programs for the same client in both the UAE and India, the company is starting its first screening project in Eastern Europe.

Diagnos Inc. Announces Board Changes

Diagnos Inc. announced the appointment of Mr. Lloyd M. Segal and Mr. Michael Singer as Directors of the Corporation following the resignations of Mr. Rich Baxter and Mr. Bruno Maruzzo. Mr. Segal is Managing Partner at Persistence Capital Partners. Mr. Segal is responsible for all aspects of PCP's investments from sourcing, evaluating and executing on investment opportunities, to managing existing investments. Mr. Segal has previously served as a director of several public and private corporations in the U.S. and Canada. Mr. Singer is a Pharmaceutical industry Chief Financial Officer and consultant with senior level experience in both public and private life science and innovative technology companies. Prior to joining DIAGNOS, Mr. Singer served as Chairman of the board of Directors of Warnex Inc.

Diagnos Inc., Annual General Meeting, Sep 25, 2014

Diagnos Inc., Annual General Meeting, Sep 25, 2014., at 10:00 Eastern Standard Time. Location: 7005, Taschereau Blvd, suite 340. Agenda: To receive the annual report of management, the audited consolidated financial statements of the corporation for the financial year ended March 31, 2014 and the independent auditor's report thereon; to elect the directors of the corporation; to re-appoint Deloitte LLP, as independent auditor of the corporation for the ensuing year and to authorize the directors to fix its remuneration; to approve the proposed amendment to the corporation's stock option plan pursuant to which the exercise period of stock options held by Directors upon termination be extended from three months to twelve months; and to transact such other business as may properly come before the meeting or any adjournment thereof.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADK:CN C$0.07 CAD +0.005

ADK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ADK.
View Industry Companies
 

Industry Analysis

ADK

Industry Average

Valuation ADK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIAGNOS INC, please visit www.diagnos.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.